.Common-Size Statement of Financial Position, Liabilities and Stockholders' Equity
Difficulty: Beginner
Eli Lilly & Co., Common-Size Consolidated Statement of Financial Position, Liabilities and Stockholders' Equity
| Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| | Short-term borrowings and current maturities of long-term debt | ||||||||||
| | Accounts payable | ||||||||||
| | Employee compensation | ||||||||||
| | Sales rebates and discounts | ||||||||||
| | Dividends payable | ||||||||||
| | Income taxes payable | ||||||||||
| | Deferred income taxes | ||||||||||
| | Other current liabilities | ||||||||||
| | Current liabilities | % | | % | | % | | % | | % | |
| | Long-term debt, excluding current maturities | ||||||||||
| | Accrued retirement benefits | ||||||||||
| | Long-term income taxes payable | ||||||||||
| | Other noncurrent liabilities | ||||||||||
| | Other liabilities | % | | % | | % | | % | | % | |
| | Total liabilities | % | | % | | % | | % | | % | |
| | Common stock, no par value | ||||||||||
| | Additional paid-in capital | ||||||||||
| | Retained earnings | ||||||||||
| | Employee benefit trust | ||||||||||
| | Accumulated other comprehensive loss | ||||||||||
| | Cost of common stock in treasury | ||||||||||
| | Total Eli Lilly and Company shareholders' equity | % | | % | | % | | % | | % | |
| | Noncontrolling interests | ||||||||||
| | Total equity | % | | % | | % | | % | | % | |
| | Total liabilities and equity | % | | % | | % | | % | | % | |
